Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?

Nik Nur Syazana Binti Nik Mohamed Kamal; Wan Nazatul Shima Shahidan

doi:10.3389/fphar.2019.01500

Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?

Front Pharmacol. 2020 Jan 20:10:1500. doi: 10.3389/fphar.2019.01500. eCollection 2019.

Authors

Nik Nur Syazana Binti Nik Mohamed Kamal¹, Wan Nazatul Shima Shahidan¹

Affiliation

¹ Craniofacial Science Laboratory, School of Dental Sciences, Universiti Sains Malaysia, Health Campus, Kubang Kerian, Malaysia.

Abstract

MicroRNAs (miRNAs) are a group of small non-coding RNAs with approximately 19-25 nucleotides that are involved in regulating a range of developmental and physiological processes. Non-exosomal circulating and exosomal miRNAs have also been proposed to be useful in diagnostics as biomarkers for diseases and different types of cancer. In this review, the quantity of miRNAs and of reliable experimental data analyses of miRNAs that come from exosomal and non-exosomal sources are discussed from the perspective of their use as biomarkers for cancer and other diseases, including viral infections, nervous system disorders, cardiovascular disorders, and diabetes. We summarize other research findings regarding the use of miRNA from these two sources as biomarkers in diagnostics and clinical use. The challenges in using miRNA from these two sources in cancer and disease diagnostics are evaluated and discussed. Validation of specific miRNA signatures as biomarkers is a critical milestone in diagnostics.

Keywords: biomarker; body fluid; exosome; miRNA; non-exosomal.

Publication types

Review